These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25759383)

  • 1. Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity.
    Akopian T; Kandror O; Tsu C; Lai JH; Wu W; Liu Y; Zhao P; Park A; Wolf L; Dick LR; Rubin EJ; Bachovchin W; Goldberg AL
    J Biol Chem; 2015 Apr; 290(17):11008-20. PubMed ID: 25759383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.
    Li M; Kandror O; Akopian T; Dharkar P; Wlodawer A; Maurizi MR; Goldberg AL
    J Biol Chem; 2016 Apr; 291(14):7465-76. PubMed ID: 26858247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.
    Akopian T; Kandror O; Raju RM; Unnikrishnan M; Rubin EJ; Goldberg AL
    EMBO J; 2012 Mar; 31(6):1529-41. PubMed ID: 22286948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection.
    Raju RM; Unnikrishnan M; Rubin DH; Krishnamoorthy V; Kandror O; Akopian TN; Goldberg AL; Rubin EJ
    PLoS Pathog; 2012 Feb; 8(2):e1002511. PubMed ID: 22359499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.
    Famulla K; Sass P; Malik I; Akopian T; Kandror O; Alber M; Hinzen B; Ruebsamen-Schaeff H; Kalscheuer R; Goldberg AL; Brötz-Oesterhelt H
    Mol Microbiol; 2016 Jul; 101(2):194-209. PubMed ID: 26919556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2.
    Benaroudj N; Raynal B; Miot M; Ortiz-Lombardia M
    BMC Biochem; 2011 Dec; 12():61. PubMed ID: 22132756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome.
    Moreira W; Santhanakrishnan S; Ngan GJY; Low CB; Sangthongpitag K; Poulsen A; Dymock BW; Dick T
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193668
    [No Abstract]   [Full Text] [Related]  

  • 8. Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase.
    Schmitz KR; Sauer RT
    Mol Microbiol; 2014 Aug; 93(4):617-28. PubMed ID: 24976069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.
    Compton CL; Schmitz KR; Sauer RT; Sello JK
    ACS Chem Biol; 2013 Dec; 8(12):2669-77. PubMed ID: 24047344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease.
    Frasinyuk MS; Kwiatkowski S; Wagner JM; Evans TJ; Reed RW; Korotkov KV; Watt DS
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3546-8. PubMed ID: 24915878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.
    Leodolter J; Warweg J; Weber-Ban E
    PLoS One; 2015; 10(5):e0125345. PubMed ID: 25933022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of high throughput screening methods for inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis.
    Fraga H; Rodriguez B; Bardera A; Cid C; Akopian T; Kandror O; Park A; Colmenarejo G; Lelievre J; Goldberg A
    Anal Biochem; 2019 Feb; 567():30-37. PubMed ID: 30543804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease.
    Taylor G; Frommherz Y; Katikaridis P; Layer D; Sinning I; Carroni M; Weber-Ban E; Mogk A
    J Biol Chem; 2022 Aug; 298(8):102202. PubMed ID: 35768046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities.
    Personne Y; Brown AC; Schuessler DL; Parish T
    PLoS One; 2013; 8(4):e60228. PubMed ID: 23560081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria.
    Moreira W; Ngan GJ; Low JL; Poulsen A; Chia BC; Ang MJ; Yap A; Fulwood J; Lakshmanan U; Lim J; Khoo AY; Flotow H; Hill J; Raju RM; Rubin EJ; Dick T
    mBio; 2015 May; 6(3):e00253-15. PubMed ID: 25944857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery.
    Schmitz KR; Carney DW; Sello JK; Sauer RT
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4587-95. PubMed ID: 25267638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allosteric switch regulates
    Vahidi S; Ripstein ZA; Juravsky JB; Rennella E; Goldberg AL; Mittermaier AK; Rubinstein JL; Kay LE
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5895-5906. PubMed ID: 32123115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb
    Schmitz KR; Handy EL; Compton CL; Gupta S; Bishai WR; Sauer RT; Sello JK
    ACS Chem Biol; 2023 Apr; 18(4):724-733. PubMed ID: 32083462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase.
    Szałaj N; Lu L; Benediktsdottir A; Zamaratski E; Cao S; Olanders G; Hedgecock C; Karlén A; Erdélyi M; Hughes D; Mowbray SL; Brandt P
    Eur J Med Chem; 2018 Sep; 157():1346-1360. PubMed ID: 30196059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.